共 39 条
- [1] GI262570, a non-thiazolidinedione, tyrosine-based PPARγ agonist improves overall metabolic control in combination with glibenclamideDIABETOLOGIA, 2000, 43 : A188 - A188Raz, IKler, LEdwards, RMcNeil, S
- [2] Monotherapy with GI262570, a non-thiazolidinedione PPARγ agonist, improves glycemic control in type 2 diabetes mellitus patients (T2DM)DIABETOLOGIA, 2000, 43 : A189 - A189Abou-Donia, MFiedorek, FTWilson, GGFrith, LPatel, J
- [3] GI262570, a non-thiazolidinedione PPARγ agonist, improves metabolic control in patients with type 2 diabetes mellitus when combined with glibenclamide treatmentDIABETES, 2000, 49 : A129 - A129Raz, IKler, LEdwards, RCMcNeil, SJ
- [4] Monotherapy with GI262570, a tyrosine-based non-thiazolidinedione PPARγ agonist, significantly reduces triglyceride and increases HDL-C concentrations in patients with Type 2 diabetes mellitusDIABETES, 2000, 49 : A39 - A39Wilson, GGAbou-Donia, MFrith, LPatel, JFiedorek, FT
- [5] Discovery and in vitro characterization of the novel, tyrosine-based, non-thiazolidinedione PPARγ agonist GI262570DIABETOLOGIA, 2000, 43 : A189 - A189Cobb, JEHenke, BRBlanchard, SG
- [6] Monotherapy with GI262570, a non-thiazolidinedione PPARγ agonist, reduces triglyceride and increases HDL-C in patients with type 2 diabetesDIABETOLOGIA, 2000, 43 : A189 - A189Fiedorek, FTWilson, GGAbou-Donia, MFrith, LPatel, J
- [7] Anti-hypertensive effect of farglitazar, a tyrosine-based non-thiazolidinedione PPARγ agonist, in patients with type 2 diabetes and hypertensionDIABETES, 2001, 50 : A117 - A117Home, PDPiaditis, GKoelendorf, KRaz, IMurphy, LSmith, PLKler, LDave, JTandy, D
- [8] The novel tyrosine-based PPARγ agonist GI262570 shows preferential binding to PPARγ complexed with RXRα and CBPDIABETES, 2000, 49 : A97 - A97Blanchard, SGKliewer, SAParks, DJMay, JM
- [9] GI262570, a tyrosine-based PPARγ agonist, reduces triglycerides and increases HDL-C concentrations in patients with type 2 diabetes mellitus when combined with glibenclamide treatmentDIABETES, 2000, 49 : A104 - A105Edwards, RCKler, LMcNeil, SJRound, P
- [10] Troglitazone monotherapy improves glycemic control in patients with type 2 diabetes mellitus: A randomized, controlled studyJOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (09): : 3169 - 3176Fonseca, VAValiquett, TRHuang, SMGhazzi, MNWhitcomb, RW